Annual Current Ratio
10.92
-1.56-12.50%
December 31, 2023
Summary
- As of February 10, 2025, CERE annual current ratio is 10.92, with the most recent change of -1.56 (-12.50%) on December 31, 2023.
- During the last 3 years, CERE annual current ratio has fallen by -2.30 (-17.40%).
Performance
CERE Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Ratio
10.22
-0.70-6.41%
March 31, 2024
Summary
- As of February 10, 2025, CERE quarterly current ratio is 10.22, with the most recent change of -0.70 (-6.41%) on March 31, 2024.
- Over the past year, CERE quarterly current ratio has increased by +1.50 (+17.20%).
Performance
CERE Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
CERE Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.5% | +17.2% |
| 3 y3 years | -17.4% | -34.8% |
| 5 y5 years | +86.7% | -34.8% |
CERE Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.6% | at low | -38.6% | -14.7% |
| 5 y | 5-year | -19.6% | -46.4% | -53.4% | -96.6% |
| alltime | all time | -19.6% | -46.4% | -53.4% | -96.6% |
Cerevel Therapeutics Holdings Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | 10.22(-6.4%) |
| Dec 2023 | 10.92(-12.5%) | 10.92(+25.2%) |
| Sep 2023 | - | 8.72(-24.0%) |
| Jun 2023 | - | 11.47(-14.1%) |
| Mar 2023 | - | 13.35(+7.0%) |
| Dec 2022 | 12.48 | 12.48(-25.0%) |
| Sep 2022 | - | 16.64(+74.8%) |
| Jun 2022 | - | 9.52(-39.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | 15.67(+15.3%) |
| Dec 2021 | 13.59(+2.8%) | 13.59(-38.0%) |
| Sep 2021 | - | 21.92(+93.3%) |
| Jun 2021 | - | 11.34(+10.7%) |
| Mar 2021 | - | 10.24(-22.5%) |
| Dec 2020 | 13.22(+126.0%) | 13.22(+3677.1%) |
| Sep 2020 | - | 0.35 |
| Dec 2019 | 5.85 | - |
FAQ
- What is Cerevel Therapeutics Holdings annual current ratio?
- What is the all time high annual current ratio for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings annual current ratio year-on-year change?
- What is Cerevel Therapeutics Holdings quarterly current ratio?
- What is the all time high quarterly current ratio for Cerevel Therapeutics Holdings?
- What is Cerevel Therapeutics Holdings quarterly current ratio year-on-year change?
What is Cerevel Therapeutics Holdings annual current ratio?
The current annual current ratio of CERE is 10.92
What is the all time high annual current ratio for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high annual current ratio is 13.59
What is Cerevel Therapeutics Holdings annual current ratio year-on-year change?
Over the past year, CERE annual current ratio has changed by -1.56 (-12.50%)
What is Cerevel Therapeutics Holdings quarterly current ratio?
The current quarterly current ratio of CERE is 10.22
What is the all time high quarterly current ratio for Cerevel Therapeutics Holdings?
Cerevel Therapeutics Holdings all-time high quarterly current ratio is 21.92
What is Cerevel Therapeutics Holdings quarterly current ratio year-on-year change?
Over the past year, CERE quarterly current ratio has changed by +1.50 (+17.20%)